شركة رقمي
نقل من موقع 
July 9 (Reuters) - The acting commissioner of the Food and Drug Administration on Friday called for a federal investigation into the agency’s approval of Biogen’s treatment for Alzheimer’s disease. (Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur) Our Standards: The Thomson Reuters Trust Principles.
مشاركة :
